Core Viewpoint - Knight Therapeutics Inc. is set to release its third quarter 2025 financial results on November 6, 2025, prior to market opening, followed by a conference call and audio webcast for interested parties [1]. Company Overview - Knight Therapeutics Inc. is a specialty pharmaceutical company based in Montreal, Canada, focusing on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America [3]. - The company's Latin American subsidiaries operate under the names United Medical, Biotoscana Farma, and Laboratorio LKM [3]. - Knight Therapeutics Inc.'s shares are traded on the TSX under the symbol GUD [3]. Event Details - The conference call is scheduled for November 6, 2025, at 8:30 a.m. ET, with a toll-free telephone number provided for participants [1]. - An audio webcast will be available for listening, and a replay will be accessible for 30 days following the event [2].
Notice of Knight Therapeutics' Third Quarter 2025 Results Conference Call
Globenewswire·2025-10-30 11:30